Open Access
Open access
Taylor & Francis
Immunological Medicine
,  страницы 1-8

Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study

Chie Ogita 1
, 
Kazuteru Noguchi 1
, 
Jiro Takeuchi 2, 3
, 
Naoto AZUMA 1
, 
Satoshi Omura 4
, 
Daiki Nakagomi 5
, 
Yoshiyuki Abe 6
, 
Masatoshi Kadoya 7
, 
Naoho Takizawa 8
, 
Atsushi Nomura 9
, 
Yuji Kukida 10
, 
Naoya Kondo 11
, 
Yasuhiko Yamano 12
, 
Takuya Yanagida 13
, 
Koji Endo 14
, 
Shintaro Hirata 15
, 
Tohru Takeuchi 16
, 
Kunihiro Ichinose 17, 18
, 
Masaru Kato 19
, 
Ryo Yanai 20
, 
Yusuke Matsuo 21, 22
, 
Yasuhiro Shimojima 23
, 
Ryo Nishioka 24
, 
Ryota Okazaki 25
, 
Tomoaki Takata 26
, 
Takafumi Ito 27
, 
Mayuko Moriyama 18
, 
Ayuko Takatani 28
, 
Yoshia Miyawaki 29
, 
Yutaka KAWAHITO 4
, 
Toshiko Ito-Ihara 30
, 
Takashi Kida 4
, 
Nobuyuki Yajima 20
, 
Takashi Kawaguchi 31
, 
Kiyoshi Matsui 1
1
 
Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo Medical University School of Medicine, Hyogo, Japan | 
2
 
Hyogo Medical University Clinical Epidemiology, Hyogo, Japan | 
3
 
4
 
5
 
6
 
7
 
Center for Rheumatic Disease, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan | 
8
 
Department of Rheumatology, Chubu Rosai Hospital, Aichi, Japan | 
9
 
10
 
Department of Rheumatology, Japanese Red Cross Society Kyoto Daini Hospital, Kyoto, Japan | 
11
 
Department of Nephrology, Kyoto Katsura Hospital, Kyoto, Japan | 
12
 
Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan | 
13
 
14
 
Department of General Internal Medicine, Tottori Redcross Hospital, Tottori, Japan | 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo, Japan | 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
Rheumatic Disease Center, Sasebo Chuo Hospital, Nagasaki, Japan | 
29
 
30
 
31
 
Тип публикации: Journal Article
Дата публикации: 2025-01-11
Taylor & Francis
scimago Q2
wos Q2
БС2
SJR: 0.880
CiteScore: 5.6
Impact factor: 2.9
ISSN: 25785826
Найдено 

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
0
Поделиться
Цитировать
ГОСТ |
Цитировать
ГОСТ Скопировать
Ogita C. et al. Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study // Immunological Medicine. 2025. pp. 1-8.
ГОСТ со всеми авторами (до 50) Скопировать
Ogita C., Noguchi K., Takeuchi J., AZUMA N., Omura S., Nakagomi D., Abe Y., Kadoya M., Takizawa N., Nomura A., Kukida Y., Kondo N., Yamano Y., Yanagida T., Endo K., Hirata S., Takeuchi T., Ichinose K., Kato M., Yanai R., Matsuo Y., Shimojima Y., Nishioka R., Okazaki R., Takata T., Ito T., Moriyama M., Takatani A., Miyawaki Y., KAWAHITO Y., Ito-Ihara T., Kida T., Yajima N., Kawaguchi T., Matsui K. Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study // Immunological Medicine. 2025. pp. 1-8.
RIS |
Цитировать
RIS Скопировать
TY - JOUR
DO - 10.1080/25785826.2024.2448912
UR - https://www.tandfonline.com/doi/full/10.1080/25785826.2024.2448912
TI - Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study
T2 - Immunological Medicine
AU - Ogita, Chie
AU - Noguchi, Kazuteru
AU - Takeuchi, Jiro
AU - AZUMA, Naoto
AU - Omura, Satoshi
AU - Nakagomi, Daiki
AU - Abe, Yoshiyuki
AU - Kadoya, Masatoshi
AU - Takizawa, Naoho
AU - Nomura, Atsushi
AU - Kukida, Yuji
AU - Kondo, Naoya
AU - Yamano, Yasuhiko
AU - Yanagida, Takuya
AU - Endo, Koji
AU - Hirata, Shintaro
AU - Takeuchi, Tohru
AU - Ichinose, Kunihiro
AU - Kato, Masaru
AU - Yanai, Ryo
AU - Matsuo, Yusuke
AU - Shimojima, Yasuhiro
AU - Nishioka, Ryo
AU - Okazaki, Ryota
AU - Takata, Tomoaki
AU - Ito, Takafumi
AU - Moriyama, Mayuko
AU - Takatani, Ayuko
AU - Miyawaki, Yoshia
AU - KAWAHITO, Yutaka
AU - Ito-Ihara, Toshiko
AU - Kida, Takashi
AU - Yajima, Nobuyuki
AU - Kawaguchi, Takashi
AU - Matsui, Kiyoshi
PY - 2025
DA - 2025/01/11
PB - Taylor & Francis
SP - 1-8
SN - 2578-5826
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2025_Ogita,
author = {Chie Ogita and Kazuteru Noguchi and Jiro Takeuchi and Naoto AZUMA and Satoshi Omura and Daiki Nakagomi and Yoshiyuki Abe and Masatoshi Kadoya and Naoho Takizawa and Atsushi Nomura and Yuji Kukida and Naoya Kondo and Yasuhiko Yamano and Takuya Yanagida and Koji Endo and Shintaro Hirata and Tohru Takeuchi and Kunihiro Ichinose and Masaru Kato and Ryo Yanai and Yusuke Matsuo and Yasuhiro Shimojima and Ryo Nishioka and Ryota Okazaki and Tomoaki Takata and Takafumi Ito and Mayuko Moriyama and Ayuko Takatani and Yoshia Miyawaki and Yutaka KAWAHITO and Toshiko Ito-Ihara and Takashi Kida and Nobuyuki Yajima and Takashi Kawaguchi and Kiyoshi Matsui},
title = {Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study},
journal = {Immunological Medicine},
year = {2025},
publisher = {Taylor & Francis},
month = {jan},
url = {https://www.tandfonline.com/doi/full/10.1080/25785826.2024.2448912},
pages = {1--8},
doi = {10.1080/25785826.2024.2448912}
}